Previous studies have demonstrated that PPA ameliorates steatosis primarily by inhibiting lipogenesis [12] and suppressing gluconeogenesis via the GPR43/AMPK pathway [54], whereas acetic acid also acts through hepatic GPR43 [14]. The gene discussed is FFAR2; the disease is steatosis.